| 4147 |
National Institute of Environmental Health Sciences |
Html |
en |
Radon |
Radon is a colorless, odorless radioactive gas. It comes from the natural decay of uranium or thorium found in nearly all soils. |
| odorless radioactive gas | 0.58726 |
| natural decay | 0.433597 |
| collaborative effort | 0.4061 |
| Human Services | 0.407374 |
| U.S. Department | 0.724431 |
| lung cancer | 0.911544 |
| thorium | 0.332058 |
| homes | 0.318095 |
| cracks | 0.327303 |
| estimates | 0.330277 |
| building materials | 0.421362 |
| non-smokers | 0.330686 |
| testing | 0.318191 |
| foundations | 0.31884 |
| water | 0.319812 |
| U.S. Department Veterans | 0.520342 |
| radon exposure | 0.747953 |
| radon mitigation | 0.631229 |
| ground | 0.319948 |
| Environmental Protection Agency | 0.69646 |
| uranium | 0.326769 |
| Federal Action Plan | 0.502228 |
| radon | 0.821957 |
| Radon Resources | 0.635261 |
| United States | 0.415227 |
|
| Urban Development | 0.407972 |
| cause | 0.338665 |
| U.S. Environmental Protection | 0.688169 |
| radon-related lung cancer | 0.568398 |
| floors | 0.320492 |
| walls | 0.318368 |
| National Cancer Institute | 0.507071 |
| Agriculture | 0.317788 |
| soils | 0.322693 |
| radioactive particles | 0.466253 |
| radon levels | 0.629744 |
| colorless | 0.338325 |
| process | 0.318081 |
| Health | 0.317848 |
| necessary steps | 0.409191 |
| People | 0.318064 |
| active smoking | 0.411149 |
| Saving Lives | 0.408872 |
| Families | 0.318049 |
| U.S. General Services | 0.509674 |
| Defense | 0.31775 |
| home | 0.319918 |
| lung cancer deaths | 0.751463 |
| Long-term exposure | 0.436003 |
|
CLICK HERE |
| 4154 |
National Institute of Environmental Health Sciences |
Html |
en |
Innate Immunity Signal Transduction in Human Leukocytes |
The Innate Immunity Signal Transduction in Human Leukocytes is a research study to determine the response of immune cells from the bloodstream. |
| blood cell function | 0.857637 |
| Innate Immunity Signal | 0.892013 |
| Recurrent fever | 0.691945 |
| research study | 0.739352 |
| participant | 0.580026 |
| Alcohol consumption | 0.680188 |
| white blood cells | 0.929239 |
| Blood pressure | 0.801272 |
| ml | 0.568081 |
| healthy adult donors | 0.845682 |
| Exposure Study | 0.739471 |
| Diarrhea | 0.538237 |
| Human Leukocytes | 0.724044 |
| dentist | 0.537883 |
| HMG CoA reductase | 0.857876 |
| BPA | 0.546679 |
| Insulin dependent diabetes | 0.82172 |
| CaREFREE Study | 0.753508 |
| Creutzfeldt-Jacob Disease | 0.671451 |
| Transduction | 0.541425 |
| lbs | 0.538272 |
| Calorie Restriction | 0.725628 |
| Ages Eligible | 0.706322 |
| Cox-2 Gene | 0.732119 |
|
| samples states | 0.670052 |
| Pulse rate | 0.661917 |
| suspected pregnancy | 0.691713 |
| Clinical Trials Study | 0.877316 |
| blood plasma | 0.738636 |
| corticosteroids | 0.544082 |
| inflammation | 0.538031 |
| cups | 0.554088 |
| possible disease-related conditions | 0.863689 |
| Bisphenol | 0.560014 |
| blood donation | 0.879466 |
| participants | 0.555679 |
| doctor visit | 0.690752 |
| bloodstream | 0.551006 |
| test tube | 0.68694 |
| substances | 0.570815 |
| Reproductive Effects | 0.70382 |
| immune cells | 0.891453 |
| antidepressants | 0.536599 |
| various signals | 0.700116 |
| Genders Eligible | 0.714599 |
| certain circumstances | 0.690168 |
| response | 0.580673 |
| antihistamines | 0.545714 |
|
CLICK HERE |
| 4156 |
National Institute of Environmental Health Sciences |
Html |
en |
Bisphenol A (BPA) Pharmacokinetic (PK): Controlled Exposure Study |
Bisphenol A (BPA) is a chemical that is used primarily to make plastics, resins, and thermal paper. |
| North Carolina | 0.404904 |
| resins | 0.235977 |
| medical history | 0.381623 |
| research study | 0.407097 |
| breastfeeding female | 0.395992 |
| low levels | 0.422271 |
| single oral dose | 0.577155 |
| Clinical Research Unit | 0.864438 |
| study period | 0.420853 |
| Regular blood samples | 0.562795 |
| volunteers | 0.234926 |
| water | 0.268032 |
| screening laboratory tests | 0.527317 |
| follow-up visit | 0.532141 |
| body absorbs | 0.401547 |
| BPA | 0.950847 |
| vanilla wafer cookie | 0.53318 |
| chemical | 0.238196 |
| Research Triangle Park | 0.877312 |
| BPA dose | 0.678802 |
| single dose | 0.599445 |
| 24-hour urine collections | 0.632026 |
| thermal paper | 0.423385 |
| CRU | 0.462451 |
|
| baby bottles | 0.417986 |
| effort | 0.258764 |
| Environmental Health Sciences | 0.535257 |
| additional blood | 0.384898 |
| NIEHS Clinical Research | 0.632204 |
| follow-up visits | 0.628047 |
| plastic products | 0.416823 |
| frequent blood tests | 0.533259 |
| place | 0.235059 |
| National Institute | 0.383375 |
| participants | 0.371129 |
| plastics | 0.238144 |
| reproductive age | 0.38114 |
| Trials Study page | 0.566642 |
| urine tests | 0.663008 |
| people | 0.237954 |
| food | 0.237865 |
| 13-hour visit | 0.506357 |
| Researchers | 0.237427 |
| study visits | 0.443822 |
| ages | 0.234675 |
| compensation | 0.25884 |
| BPA-containing products | 0.397451 |
| time | 0.321999 |
|
CLICK HERE |
| 4157 |
National Institute of Environmental Health Sciences |
Html |
en |
Blood Vessel Study |
The endothelium is the inner lining of blood vessels. The cells in this lining help regulate blood flow and immune system function. |
| North Carolina | 0.593975 |
| certain diseases | 0.51467 |
| medical history | 0.592865 |
| Sample collections | 0.495826 |
| arteries | 0.42047 |
| research study | 0.513955 |
| Participants | 0.488437 |
| certain genes | 0.626794 |
| electrocardiogram | 0.425687 |
| informed consent | 0.506292 |
| genetic risk | 0.505664 |
| blood flow | 0.602203 |
| contact Grace Isshiki | 0.583686 |
| endothelial function | 0.644334 |
| single study visit | 0.622939 |
| Clinical Research Unit | 0.904054 |
| Sciences Clinical Research | 0.585233 |
| blood vessels | 0.593264 |
| urine samples | 0.514808 |
| artery | 0.445869 |
| Protocol Number | 0.496279 |
| Research Triangle Park | 0.923425 |
| inner lining | 0.614816 |
| problems | 0.433444 |
| immune system function | 0.514997 |
|
| endothelial cells | 0.557885 |
| healthy adults | 0.503616 |
| short-acting dose | 0.494919 |
| blood samples | 0.503224 |
| CRU | 0.449371 |
| short-acting medication | 0.499172 |
| NIEHS Clinical Research | 0.776132 |
| protocol procedures | 0.497126 |
| Clinical Trials Study | 0.600871 |
| study procedures | 0.506002 |
| current participant | 0.501346 |
| nitroglycerin | 0.442508 |
| heart disease | 0.514134 |
| Environmental Polymorphisms Registry | 0.586863 |
| place | 0.433692 |
| arm | 0.436358 |
| National Institute | 0.496202 |
| endothelium | 0.431348 |
| ultrasound | 0.436314 |
| high blood pressure | 0.619133 |
| information | 0.466386 |
| compensation | 0.428407 |
| time | 0.433266 |
| physical exam | 0.59612 |
|
CLICK HERE |
| 4194 |
National Institute of Environmental Health Sciences |
Html |
en |
Nanomaterials |
Scientists have not unanimously settled on a precise definition of nanomaterials, but agree that they are partially characterized by their tiny size, measured in nanometers. |
| Fibrous nanomaterials | 0.773043 |
| environmental health implications | 0.718338 |
| Engineered Nanomaterials Grand | 0.815837 |
| nanoscale materials | 0.817175 |
| potential health effects | 0.795725 |
| contain nanomaterials | 0.736609 |
| drug delivery | 0.723282 |
| environmental health | 0.814497 |
| human health | 0.873144 |
| Disease – Nanotechnology | 0.727563 |
| research program | 0.72157 |
| NIEHS | 0.932033 |
| nanotechnology application program | 0.765562 |
| NIEHS researchers | 0.820731 |
| NIEHS Nano Environmental | 0.845135 |
| hazardous waste sites | 0.720255 |
| NTP Nanotechnology | 0.718092 |
| nanomaterials | 0.958248 |
| potential health risks | 0.740628 |
| NIEHS Worker Education | 0.7818 |
| Environmental Protection Agency | 0.814282 |
| strategic research program | 0.718293 |
| potential risks | 0.717192 |
| Nanotechnology Characterization Laboratory | 0.745696 |
|
| National Toxicology Program | 0.763591 |
| States National Nanotechnology | 0.766907 |
| carbon nanoparticles | 0.739552 |
| Occupational Safety | 0.73954 |
| adverse health effects | 0.714494 |
| Nature Nanotechnology | 0.726959 |
| prevalent nanomaterials | 0.741262 |
| carbon nanotubes | 0.776764 |
| Nanotechnology Programs | 0.715286 |
| class nanotechnology research | 0.767614 |
| environmental health sciences | 0.786118 |
| National Institute | 0.789046 |
| Nanotechnology Health Implications | 0.803056 |
| potential human health | 0.739087 |
| NIEHS Centers | 0.777873 |
| Consumer Product Safety | 0.720144 |
| NIH research activities | 0.713657 |
| NIEHS grantees | 0.81039 |
| NIH Research Portfolio | 0.713264 |
| NIEHS’s efforts | 0.756112 |
| Superfund Research Program | 0.711646 |
| National Nanotechnology Initiative | 0.968948 |
| NIEHS WETP | 0.75467 |
| hazardous waste | 0.748002 |
|
CLICK HERE |
| 4229 |
National Institute of Environmental Health Sciences |
Html |
en |
The Role of TGF-Beta in Asthmatic Epithelial Cell Susceptibility to RSV Infection |
Asthma patients seem to be more prone to viral infections, and NIEHS scientists believe that the cells that line these patients' airways, cause this result by overproducing TGF-beta1, a protein that promotes viral growth. |
| research team member | 0.420993 |
| North Carolina | 0.256008 |
| Non-smoking healthy adults | 0.41552 |
| final eligibility visit | 0.499939 |
| mild asthmatic participants | 0.793821 |
| medical history | 0.438584 |
| alveolar macrophages | 0.492495 |
| blood samples | 0.274456 |
| physical examination | 0.43791 |
| viral growth | 0.302566 |
| RSV infection | 0.525917 |
| NIEHS Clinical Research | 0.412814 |
| bronchoscopy | 0.334615 |
| viral infections | 0.311347 |
| inflammatory activity | 0.264911 |
| asthmatic epithelial susceptibility | 0.915952 |
| pulmonary function tests | 0.412673 |
| Asthma patients | 0.301404 |
| pulmonary function test | 0.434215 |
| contact Grace Isshiki | 0.414398 |
| vital signs | 0.262381 |
| airway cell samples | 0.469717 |
|
| blood draw | 0.261382 |
| NIEHS scientists | 0.334267 |
| pulmonary function | 0.448955 |
| study visit | 0.481064 |
| Trials Study page | 0.468853 |
| epithelial cells | 0.371544 |
| RSV infections | 0.358391 |
| primary objective | 0.257984 |
| medical history review | 0.403741 |
| asthmatic bronchial epithelia | 0.722628 |
| screening visit | 0.45057 |
| non-asthmatic participants | 0.357239 |
| Growth Factor-beta | 0.270314 |
| RSV replication | 0.353971 |
| controlled study | 0.29404 |
| Protocol Number | 0.268367 |
| Research Triangle Park | 0.38372 |
| laboratory analysis | 0.25923 |
| collect lung cells | 0.424885 |
| Potential participants | 0.355279 |
| normal epithelia | 0.491212 |
| respiratory syncytial virus | 0.419629 |
|
CLICK HERE |
| 4231 |
National Institute of Environmental Health Sciences |
Html |
en |
Studies in the Natural History & Pathogenesis of Childhood-Onset and Adult-Onset Idiopathic Inflammatory Myopathies |
This study will evaluate subjects with adult- and childhood-onset myositis to learn more about their causes and the immune system changes and medical problems associated with them. |
| Inclusion Criteria | 0.501112 |
| Healthy volunteers | 0.460173 |
| following criteria | 0.490113 |
| research purposes | 0.458042 |
| blood tests | 0.479663 |
| physical examination | 0.931824 |
| complete history | 0.457581 |
| muscle biopsy | 0.495727 |
| immune system changes | 0.489858 |
| Clinical Center | 0.589852 |
| Referral/Patient Recruitment | 0.455552 |
| blood specimen | 0.623839 |
| 5-day evaluation | 0.455186 |
| medical problems | 0.498329 |
| National Institutes | 0.447029 |
| single visit | 0.454877 |
| autoimmune muscle disease | 0.678141 |
| patients | 0.474675 |
| urine samples | 0.521257 |
| Magnuson Clinical Center | 0.578761 |
| IIM | 0.393113 |
| undefined illnesses | 0.481726 |
| Protocol Number | 0.453711 |
| data collection study | 0.609228 |
| Idiopathic Inflammatory Myopathies | 0.641762 |
|
| minimum assessment | 0.633749 |
| Exclusion Criteria | 0.490335 |
| childhood-onset myositis | 0.615462 |
| local doctor | 0.452006 |
| research procedures | 0.450164 |
| MRI examination | 0.494087 |
| chronic muscle weakness | 0.686902 |
| NIH Clinical Center | 0.576579 |
| environmental risk factors | 0.637835 |
| inflammatory muscle disease | 0.690546 |
| intensive care | 0.456153 |
| comprehensive history | 0.617507 |
| prpl@mail.cc.nih.gov | 0.45965 |
| Trials Study page | 0.647387 |
| urine tests | 0.480773 |
| optimal site | 0.464941 |
| significant disability | 0.483355 |
| elevated CK | 0.47874 |
| Rockville Pike | 0.447491 |
| principal investigator | 0.453991 |
| genetics portion | 0.461805 |
| definite criteria | 0.499066 |
| medical records | 0.768894 |
| available first degree | 0.464805 |
|
CLICK HERE |
| 4242 |
National Institute of Environmental Health Sciences |
Html |
en |
Sample Collection Registry for Quality Control of Biological and Environmental Specimens and Assay Development and Testing |
Researchers are interested in developing a registry protocol to obtain biologic and environmental samples anonymously from adult volunteers for use in laboratory tests and studies. |
| Blood samples | 0.546281 |
| stool | 0.42285 |
| quality control purposes | 0.75419 |
| urine | 0.413236 |
| research purposes | 0.525859 |
| research study | 0.514841 |
| biologic samples | 0.57011 |
| number | 0.338636 |
| monetary compensation | 0.521038 |
| blood sample | 0.741268 |
| past 24-hour questionnaire | 0.718462 |
| ml | 0.340737 |
| Eligible participants | 0.569871 |
| biological sample | 0.513563 |
| clinical research unit | 0.958713 |
| blood draw | 0.716242 |
| household dust | 0.760388 |
| researchers | 0.387354 |
| laboratory tests | 0.55514 |
| nail clippings | 0.77694 |
| scientists | 0.337487 |
| occasions | 0.33738 |
| nasal cells | 0.823784 |
| one-time sample collection | 0.742045 |
| role | 0.33737 |
|
| sputum | 0.381459 |
| standard clinical protocols | 0.713022 |
| disease risk | 0.515689 |
| NIEHS Clinical Research | 0.766087 |
| genetic factors | 0.509698 |
| new tests | 0.552702 |
| hair | 0.381797 |
| total | 0.33715 |
| NIEHS investigators | 0.581949 |
| breath condensate | 0.559727 |
| specified period | 0.537353 |
| cheek cells | 0.823814 |
| types | 0.338613 |
| environmental samples | 0.728334 |
| Trials Study page | 0.741047 |
| registry protocol | 0.556228 |
| specimens | 0.445811 |
| sperm | 0.402188 |
| assay development/testing | 0.523007 |
| skin cells | 0.792963 |
| saliva | 0.424689 |
| adult volunteers | 0.562648 |
| noninvasive samples | 0.56313 |
| research studies | 0.553052 |
|
CLICK HERE |
| 16617 |
National Institute of Environmental Health Sciences |
Html |
en |
Inhaled Nanosilver Study |
The goal of the Inhaled Nanosilver Study is to assess the impact of inhaled silver nanoparticles on immune responses in the lung. |
| clothing fabrics | 0.527999 |
| medical history | 0.510235 |
| collect blood | 0.51117 |
| CRU | 0.427233 |
| Inhaled Nanosilver Study | 0.956317 |
| research study | 0.529102 |
| consumer products | 0.527538 |
| physical exams | 0.50777 |
| Environmental Health Sciences | 0.608537 |
| Participants | 0.418628 |
| lung function testing | 0.642752 |
| immune responses | 0.551871 |
| treatment visit | 0.526739 |
| supplies | 0.420467 |
| medications | 0.418968 |
| NIEHS | 0.432183 |
| place | 0.418211 |
| National Institute | 0.513463 |
| breathing tests | 0.525338 |
| medical information | 0.506261 |
| vital signs | 0.50996 |
| goal | 0.420987 |
|
| Clinical Research Unit | 0.609693 |
| manufacturers | 0.419072 |
| campus | 0.418061 |
| impact | 0.420904 |
| inhaled silver nanoparticles | 0.6956 |
| Trials Study page | 0.610765 |
| urine samples | 0.534709 |
| bronchoscopy procedures | 0.548218 |
| nebulizer | 0.43531 |
| nanosilver solution | 0.714958 |
| people | 0.419157 |
| water | 0.419103 |
| biological samples | 0.506562 |
| market | 0.419173 |
| inhalation | 0.427751 |
| help | 0.419057 |
| team members | 0.511496 |
| study visits | 0.592775 |
| Research Triangle Park | 0.609899 |
| antimicrobial properties | 0.538094 |
| physical exam | 0.50991 |
|
CLICK HERE |
| 16621 |
National Institute of Environmental Health Sciences |
Html |
en |
Psoriasis Study |
This project will evaluate whether the presence of a protein, called Stim1, in blood immune cells modifies differently the immune response between a person with psoriasis, a person with a chronic inflammatory disease, and a healthy person. |
| Calorie Restriction | 0.634688 |
| Research Triangle park | 0.700499 |
| one-hour study visit | 0.722254 |
| Participants | 0.430223 |
| Unit | 0.426802 |
| NIEHS Clinical Research | 0.754435 |
| Donate blood | 0.563463 |
| capacity | 0.432936 |
| monetary compensation | 0.567799 |
| immune response | 0.772377 |
| inflammation | 0.445097 |
| protein | 0.47846 |
| presence | 0.433295 |
| blood immune cells | 0.823074 |
|
| calcium changes | 0.583799 |
| Evaluation | 0.431596 |
| Reproductive Effects | 0.597091 |
| immune response differences | 0.739662 |
| urine sample | 0.575455 |
| chronic inflammatory disease | 0.935793 |
| psoriasis | 0.499148 |
| CaREFREE Study | 0.611946 |
| Environment | 0.431746 |
| breastfeeding | 0.443199 |
| healthy person | 0.621262 |
| research project | 0.640191 |
| influences cells | 0.610261 |
|
CLICK HERE |